Regulators in Europe just backed Novo's heavyweight Wegovy--setting the stage for a head-to-head obesity drug showdown in ...

Novo Nordisk's 7.2 mg Wegovy injectable aims to enhance chronic weight management in adults with obesity, using an expedited FDA review process. The Phase III STEP UP trial showed semaglutide 7.2 mg's ...

The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...

A Wegovy weight loss pill could soon be a reality after tests showed taking the once-daily oral medication was about as successful at helping people lose weight as its injectable form. People who were ...

The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...

Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled WEgovy Real ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. What Happens If You Use Expired Semaglutide? Wondering what ...

Weight loss drugs like Wegovy and Ozempic have helped millions in their weight loss (and diabetes) journeys. Now, Novo Nordisk—the creator of Wegovy—has published results of a once-daily oral ...

Drugs like Wegovy and Ozempic have become increasingly popular options for millions of people who want to reach a healthier weight. But the drugs, taken as weekly injections, aren't for everybody or ...

The MarketWatch News Department was not involved in the creation of this content. -- New data from OASIS 4 on oral semaglutide 25 mg to reveal insights on cardiometabolic health among adults with ...

Bills on diagnostic breast cancer testing, GLP-1 medications, lead paint and breastfeeding were signed into law.